Irritable Mood
20
6
6
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
2 terminated out of 20 trials
80.0%
-6.5% vs benchmark
15%
3 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
Parent Management Training to Treat Irritability
Estrogen Variability and Irritability During the Menopause Transition
Focus Groups in Ethnically and Racially Diverse Families
Dose Response Relationship of Oxytocin on Irritability in Youths
Stop, Focus, Plan, and Change: Predicting Parent and Child Responses to a Brief, Telehealth Parent Training
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms
Hostile Interpretation Bias Training to Treat Irritability
RESist Against Irritability Superiority Trial
Irritability in Children With ADHD and Emotion Dysregulation
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Dextromethorphan Added on for Children With Chronic Irritability
Examining the Impacts on In-School Behaviors of In-Home Videogame Play
Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
Digital Parent Training for Disruptive Behaviors in Children
Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.